These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 2077408)
21. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA Nephron; 1997; 75(4):412-9. PubMed ID: 9127327 [TBL] [Abstract][Full Text] [Related]
22. Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy. Pecovnik Balon B; Bren A Clin Nephrol; 2000 Dec; 54(6):463-9. PubMed ID: 11140807 [TBL] [Abstract][Full Text] [Related]
24. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Bervoets AR; Spasovski GB; Behets GJ; Dams G; Polenakovic MH; Zafirovska K; Van Hoof VO; De Broe ME; D'Haese PC Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034 [TBL] [Abstract][Full Text] [Related]
25. Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients. Piscitelli J; Cabansag MR; Silverstein DM J Pediatr Endocrinol Metab; 1999; 12(6):879-86. PubMed ID: 10614547 [TBL] [Abstract][Full Text] [Related]
26. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Moore C; Yee J; Malluche H; Rao DS; Monier-Faugere MC; Adams E; Daramola-Ogunwuyi O; Fehmi H; Bhat S; Osman-Malik Y Clin J Am Soc Nephrol; 2009 Sep; 4(9):1484-1493. PubMed ID: 19713297 [TBL] [Abstract][Full Text] [Related]
27. Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women. Parker CR; Blackwell PJ; Freemont AJ; Hosking DJ Am J Kidney Dis; 2002 Aug; 40(2):385-96. PubMed ID: 12148113 [TBL] [Abstract][Full Text] [Related]
28. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703 [TBL] [Abstract][Full Text] [Related]
29. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis]. Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338 [TBL] [Abstract][Full Text] [Related]
30. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure. Coen G; Mazzaferro S; Ballanti P; Bonucci E J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330 [No Abstract] [Full Text] [Related]
31. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]. Nowak Z; Konieczna M; Wańkowicz Z Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322 [TBL] [Abstract][Full Text] [Related]
32. Bone histomorphometry in hemodialysed patients. de Vernejoul MC; Kuntz D; Miravet L; Gueris J; Bielakoff J; Ryckewaert A Metab Bone Dis Relat Res; 1981; 3(3):175-9. PubMed ID: 7347793 [TBL] [Abstract][Full Text] [Related]
33. Correlations between bone histopathology and serum biochemistry in uremic patients on chronic hemodialysis. Canavese C; Barolo S; Gurioli L; Cadario A; Portigliatti M; Isaia G; Thea A; Marangella M; Bongiorno P; Cavagnino A; Peona C; Boero R; D'Amicone M; Cardelli R; Rossi P; Piccoli G Int J Artif Organs; 1998 Aug; 21(8):443-50. PubMed ID: 9803345 [TBL] [Abstract][Full Text] [Related]
34. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266 [TBL] [Abstract][Full Text] [Related]
35. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure. Ziółkowska H; Pańczyk-Tomaszewska M; Majkowska Z; Rajkowski T; Debiński A; Przedlacki J; Sawicki A; Ostrowski K; Marciński A; Roszkowska-Blaim M Med Sci Monit; 2001; 7(5):1034-42. PubMed ID: 11535955 [TBL] [Abstract][Full Text] [Related]
36. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018 [TBL] [Abstract][Full Text] [Related]
37. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317 [TBL] [Abstract][Full Text] [Related]
38. Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy. Drüeke T; Bordier PJ; Man NK; Jungers P; Marie P Kidney Int; 1977 Apr; 11(4):267-74. PubMed ID: 857076 [TBL] [Abstract][Full Text] [Related]
39. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry. Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809 [TBL] [Abstract][Full Text] [Related]